patent/MA-27358-A1

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42eeb8b1707e0ca53ff8062568e106b5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_581265968346f63692c94fc23fc6bae3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85a482ddca1e71e472aaf88f44c7caf1
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate	2004-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eea0968ad87c5aa7f8d182e58366f3f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bc57da909a53309518c69ad675301f3
publicationDate	2005-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	MA-27358-A1
titleOfInvention	PHARMACEUTICAL COMPOSITION COMPRISING ARSENITE AND INTENDED FOR THE TREATMENT OF MALIGNANCIES.
abstract	The invention relates to a pharmaceutical composition for the treatment of solid malignant tumors chosen from the group formed by colon tumors, gastric tumors, mammary tumors, ovarian tumors, prostate tumors and kidney tumors, said composition comprising a meta-arsenite salt (AsO2-) and a pharmaceutical adjuvant. The invention also relates to the use of this composition and to a treatment method.
priorityDate	2004-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID544 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584777

Total number of triples: 16.